News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
75,551 Results
Type
Article (2295)
Company Profile (21)
Press Release (73235)
Section
Business (32581)
Career Advice (30)
Deals (5139)
Drug Delivery (2)
Drug Development (9329)
Employer Resources (7)
FDA (1618)
Job Trends (1937)
News (46355)
Policy (2642)
Tag
2027 Biotech Bay Standard (1)
Academia (199)
Academic (1)
Accelerated approval (5)
Allergies (21)
Alliances (2947)
ALS (6)
Alzheimer's disease (229)
Antibody-drug conjugate (ADC) (46)
Approvals (1721)
Artificial intelligence (25)
Autoimmune disease (14)
Automation (4)
Bankruptcy (12)
Best Places to Work (1827)
BIOSECURE Act (1)
Biosimilars (13)
Biotechnology (9)
Bladder cancer (43)
Brain cancer (2)
Breast cancer (212)
Cancer (788)
Cardiovascular disease (41)
Career advice (30)
Career pathing (3)
CAR-T (13)
CDC (3)
Cell therapy (51)
Cervical cancer (7)
Clinical research (8659)
Collaboration (121)
Compensation (66)
Complete response letters (1)
COVID-19 (200)
CRISPR (8)
C-suite (25)
Cystic fibrosis (18)
Data (1041)
Depression (15)
Diabetes (60)
Diagnostics (820)
Digital health (6)
Diversity, equity & inclusion (1)
Drug discovery (21)
Drug pricing (7)
Duchenne muscular dystrophy (25)
Earnings (29594)
Editorial (3)
Employer branding (1)
Employer resources (6)
Events (8379)
Executive appointments (36)
FDA (2190)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (62)
Gene editing (14)
Generative AI (1)
Gene therapy (63)
GLP-1 (118)
Government (329)
Guidances (267)
Healthcare (2430)
HIV (14)
Huntington's disease (10)
IgA nephropathy (18)
Immunology and inflammation (34)
Immuno-oncology (7)
Indications (20)
Infectious disease (233)
Inflammatory bowel disease (16)
Influenza (15)
Intellectual property (22)
Interviews (3)
IPO (3791)
IRA (2)
Job creations (180)
Job search strategy (26)
JPM (2)
Kidney cancer (5)
Labor market (12)
Layoffs (37)
Legal (416)
Liver cancer (10)
Longevity (1)
Lung cancer (106)
Lymphoma (85)
Management (2)
Manufacturing (35)
MASH (19)
Medical device (1861)
Medtech (1869)
Mergers & acquisitions (1444)
Metabolic disorders (123)
Multiple sclerosis (29)
NASH (3)
Neurodegenerative disease (31)
Neuropsychiatric disorders (12)
Neuroscience (371)
NextGen: Class of 2026 (495)
Non-profit (261)
Now hiring (3)
Obesity (42)
Opinion (5)
Ovarian cancer (25)
Pain (15)
Pancreatic cancer (34)
Parkinson's disease (25)
Partnered (1)
Patents (35)
Patient recruitment (25)
Peanut (8)
People (2510)
Pharmaceutical (6)
Pharmacy benefit managers (1)
Phase 1 (2027)
Phase 2 (3526)
Phase 3 (3789)
Pipeline (1550)
Policy (7)
Postmarket research (345)
Preclinical (653)
Press Release (1)
Prostate cancer (32)
Psychedelics (1)
Radiopharmaceuticals (28)
Rare diseases (97)
Real estate (301)
Recruiting (3)
Regulatory (2355)
Reports (19)
Research institute (196)
Resumes & cover letters (2)
Rett syndrome (6)
RSV (10)
Schizophrenia (24)
Series A (5)
Series B (8)
Service/supplier (1)
Sickle cell disease (7)
Special edition (3)
Spinal muscular atrophy (38)
Sponsored (4)
Startups (147)
State (1)
Stomach cancer (3)
Supply chain (10)
Tariffs (6)
The Weekly (1)
Vaccines (64)
Venture capital (8)
Weight loss (28)
Women's health (8)
Worklife (2)
Date
Today (43)
Last 7 days (109)
Last 30 days (266)
Last 365 days (4718)
2026 (350)
2025 (4700)
2024 (5391)
2023 (6383)
2022 (7151)
2021 (7479)
2020 (6737)
2019 (5310)
2018 (3879)
2017 (3293)
2016 (2548)
2015 (3268)
2014 (2240)
2013 (1422)
2012 (1805)
2011 (2109)
2010 (1959)
Location
Africa (47)
Alabama (8)
Arizona (22)
Asia (3877)
Australia (490)
California (1573)
Canada (409)
China (100)
Colorado (71)
Connecticut (77)
Delaware (90)
Europe (14879)
Florida (212)
Georgia (43)
Idaho (5)
Illinois (88)
India (3)
Indiana (130)
Japan (86)
Kansas (16)
Kentucky (6)
Louisiana (8)
Maine (15)
Maryland (160)
Massachusetts (1085)
Michigan (35)
Minnesota (99)
Missouri (17)
Montana (4)
Nebraska (1)
Nevada (10)
New Hampshire (11)
New Jersey (569)
New York (381)
North Carolina (182)
Northern California (885)
Ohio (41)
Oklahoma (1)
Oregon (6)
Pennsylvania (300)
Puerto Rico (3)
Rhode Island (1)
South America (73)
South Carolina (4)
Southern California (585)
Tennessee (19)
Texas (227)
United States (5591)
Utah (41)
Virginia (20)
Washington D.C. (6)
Washington State (130)
Wisconsin (9)
75,551 Results for "46".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
PharmaEssentia Shores up Supply with $46M Investment in Puerto Rico Plant
The Taiwan-based company is establishing a manufacturing center for the U.S. market.
February 11, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Normunity to Participate in the TD Cowen 46ᵗʰ Annual Health Care Conference
February 4, 2026
·
1 min read
Press Releases
Johnson & Johnson to Participate in the TD Cowen 46th Annual Health Care Conference
February 3, 2026
·
1 min read
Press Releases
Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
February 2, 2026
·
1 min read
Earnings
Lilly’s GLP-1s Mounjaro, Zepbound Push Revenue up 46% in Q4
Mounjaro and Zepbound combined for $11.7 billion in the fourth quarter, which beat analyst consensus of $10.6 billion.
February 4, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference
February 5, 2026
·
1 min read
Press Releases
Immutep Receives A$4.6 million R&D Tax Incentive from French Government
November 4, 2025
·
1 min read
Press Releases
POP Biotechnologies Awarded $2.46M NIH Grant for Alzheimer’s Immunotherapy
October 2, 2025
·
3 min read
Press Releases
ReviR Therapeutics Receives $4.6 Million CIRM Grant to Advance Huntington’s Disease Treatment and Announces Key Development Milestone
November 21, 2025
·
4 min read
Press Releases
Rarity PBC Raises $4.6 Million Seed Financing to Advance Gene Therapy for ADA-SCID
October 30, 2025
·
4 min read
1 of 7,556
Next
